Endocrine therapy with or without inhibition of epidermal growth factor receptor and human epidermal growth factor receptor 2: a randomized, double-blind, placebo-controlled phase III trial of fulvestrant with or without lapatinib for postmenopausal (Q34611634)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Endocrine therapy with or without inhibition of epidermal growth factor receptor and human epidermal growth factor receptor 2: a randomized, double-blind, placebo-controlled phase III trial of fulvestrant with or without lapatinib for postmenopausal |
scientific article |
Statements
1 reference
Endocrine therapy with or without inhibition of epidermal growth factor receptor and human epidermal growth factor receptor 2: a randomized, double-blind, placebo-controlled phase III trial of fulvestrant with or without lapatinib for postmenopausal (English)
1 reference
Harold J Burstein
1 reference
Constance T Cirrincione
1 reference
Eric P Winer
1 reference
Sara M Tolaney
1 reference
Clifford A Hudis
1 reference
Kimberly L Blackwell
1 reference
William T Barry
1 reference
Helen K Chew
1 reference
Diana E Lake
1 reference
Cynthia Ma
1 reference
27 October 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference